APA (7th ed.) Citation

Althoff, F. C., Hummel, H., Kokowski, K., Elender, C., Grah, C., Zacharias, S., . . . Sebastian, M. (2026). Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315). European journal of cancer, 236, . https://doi.org/10.1016/j.ejca.2026.116265

Chicago Style (17th ed.) Citation

Althoff, Friederike Cornelia, et al. "Institutional Variability in Testing for Actionable Genetic Alterations in Patients with Stage IIIB/C or IV Non-small Cell Lung Cancer: A Real-world Study from the German Prospective, Observational, Multicenter CRISP Registry (AIO-TRK-0315)." European Journal of Cancer 236 (2026). https://doi.org/10.1016/j.ejca.2026.116265.

MLA (9th ed.) Citation

Althoff, Friederike Cornelia, et al. "Institutional Variability in Testing for Actionable Genetic Alterations in Patients with Stage IIIB/C or IV Non-small Cell Lung Cancer: A Real-world Study from the German Prospective, Observational, Multicenter CRISP Registry (AIO-TRK-0315)." European Journal of Cancer, vol. 236, 2026, https://doi.org/10.1016/j.ejca.2026.116265.